37 related articles for article (PubMed ID: 19179889)
21. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
22. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
[TBL] [Abstract][Full Text] [Related]
23. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
Gillespie S; Borrow J; Zhang XD; Hersey P
Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
[TBL] [Abstract][Full Text] [Related]
25. Low-dose combinations of LBH589 and TRAIL can overcome TRAIL-resistance in colon cancer cell lines.
Lee SC; Cheong HJ; Kim SJ; Yoon J; Kim HJ; Kim KH; Kim SH; Kim HJ; Bae SB; Kim CK; Lee N; Lee KT; Park SK; Hong DS; Park HS; Won JH
Anticancer Res; 2011 Oct; 31(10):3385-94. PubMed ID: 21965751
[TBL] [Abstract][Full Text] [Related]
26. A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL.
Symanowski J; Vogelzang N; Zawel L; Atadja P; Pass H; Sharma S
J Thorac Oncol; 2009 Feb; 4(2):149-60. PubMed ID: 19179889
[TBL] [Abstract][Full Text] [Related]
27. The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.
Zhang XD; Gillespie SK; Borrow JM; Hersey P
Biochem Pharmacol; 2003 Oct; 66(8):1537-45. PubMed ID: 14555232
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
Sonnemann J; Gänge J; Kumar KS; Müller C; Bader P; Beck JF
Invest New Drugs; 2005 Mar; 23(2):99-109. PubMed ID: 15744585
[TBL] [Abstract][Full Text] [Related]
29. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia.
Saraei R; Soleimani M; Movassaghpour Akbari AA; Farshdousti Hagh M; Hassanzadeh A; Solali S
Biomed Pharmacother; 2018 Nov; 107():1010-1019. PubMed ID: 30257312
[TBL] [Abstract][Full Text] [Related]
30. Modulation of TRAIL-induced apoptosis by HDAC inhibitors.
Fulda S
Curr Cancer Drug Targets; 2008 Mar; 8(2):132-40. PubMed ID: 18336196
[TBL] [Abstract][Full Text] [Related]
31. XIAP, the guardian angel.
Holcik M; Korneluk RG
Nat Rev Mol Cell Biol; 2001 Jul; 2(7):550-6. PubMed ID: 11433370
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]